Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) October 25 – 27, 2024!

For more Information and Register: Delaware ACC By the Sea: 2024 Chapter Meeting

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

ACC.25 Convocation Incoming Presidentâ€™s Address: Christopher Kramer, MD, FACC
It is my great honor to serve this wonderful community as your 76th president. I would like to start by congratulating all of you who are receiving your FACC and AACC designations today.
ACC.25 Convocation Outgoing Presidentâ€™s Address: Cathleen Biga, MSN, MACC
Dr. Kramer, Board of Trustees members, distinguished award winners, new Fellows and Associates, global partners, past presidents, colleagues, family, and friends, as I stand here today, I can't help but reflect on the incredible journey we've had together this year, including the last three days.
ACC.25 Science Presents New Applications For AI in the Clinical Setting
The latest science coming out of ACC.25, held March 29-31 in Chicago, IL, illuminated new approaches in how artificial intelligence (AI) can be used to improve the efficiency of cardiovascular care, expand the reach into underserved communities and more.
New Report From The Lancet Commission Calls for Reframing and Redefining Approach to CAD
â€œRefocusing and reframing the definition and discussion of coronary artery disease (CAD) from late-stage ischemia and acute coronary events to early detection of coronary artery atheroma and prevention of advanced acute coronary syndrome (ACS) has the potential to save 8.7 million lives globally every year,â€ according to a new report from The Lancet Commission presented […]
A Study of Solbinsiran in Participants With Mixed Dyslipidemia
The goal of the phase 2 PROLONG-ANG3 trial was to assess the durability and efficacy of different doses of solbinsiran in reducing concentrations of atherogenic lipoproteins in adults with mixed dyslipidemia. Mixed dyslipidemia is characterized by elevated concentrations of circulating triglycerides and low-density lipoprotein cholesterol [LDL-C]).